01 1KEKULE PHARMA LIMITED
02 1Sionc Pharmaceutical Private Limited
01 1NILUTAMIDE
02 1Nilutamide
01 2India
NDC Package Code : 53220-123
Start Marketing Date : 2016-04-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76055-0012
Start Marketing Date : 2019-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Nilandron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nilandron, including repackagers and relabelers. The FDA regulates Nilandron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nilandron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nilandron manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nilandron supplier is an individual or a company that provides Nilandron active pharmaceutical ingredient (API) or Nilandron finished formulations upon request. The Nilandron suppliers may include Nilandron API manufacturers, exporters, distributors and traders.
click here to find a list of Nilandron suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nilandron as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nilandron API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nilandron as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nilandron and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nilandron NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nilandron suppliers with NDC on PharmaCompass.
We have 2 companies offering Nilandron
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
